Story

10-Year Treasury Yield Tops 5% as Fed Hikes, But Deeper Risks Remain, Zheshang Securities Warns

ENTHMSVIIDZHZH-TWJAKOHI
Sep 20, 20262 min read
10-Year Treasury Yield Tops 5% as Fed Hikes, But Deeper Risks Remain, Zheshang Securities Warns

Summary

The 10-year U.S. Treasury yield briefly crossed 5% before a hawkish Fed rate hike provided temporary relief. However, analysts at Zheshang Securities warn that unresolved fiscal pressures and inflation risks could push yields significantly higher, threatening U.S. stocks.

Text size
Background

The benchmark 10-year U.S. Treasury yield briefly surpassed the key 5.00% threshold before retreating after the Federal Reserve's latest interest rate decision. While the Fed's move stabilized the bond market in the short term, the fundamental issues driving yields higher have not been resolved, according to a research report from Zheshang Securities.

Fed's Hawkish Hike

The Federal Open Market Committee (FOMC) raised the federal funds rate target range by 25 basis points to 3.75%-4.00%, a move that was widely expected. The decision was unanimous, which Zheshang Securities interpreted as a sign of strengthening hawkish sentiment within the central bank.

Fed projections also pointed to a more aggressive stance, with the median forecast for the policy rate at the end of 2026 rising to 4.1%. The committee's dot plot showed that 12 of 18 officials anticipate at least one more 25-basis-point hike this year. The brokerage noted that the Fed's decisive action helped reassure investors of its independence and commitment to fighting inflation, providing temporary relief to a market concerned about a lack of monetary discipline.

Root Causes of High Yields Persist

Despite the market's initial positive reaction, Zheshang Securities warns that the upward trend in Treasury yields is likely to continue. The report suggests the 10-year yield could still have 50 to 100 basis points of potential upside, citing unresolved structural problems.

Sample IUX Markets – In-articleAd

Key underlying drivers include:

  • U.S. Fiscal Imbalance: The report highlights that total U.S. national debt has exceeded $40 trillion. In the first 11 months of fiscal year 2026, the budget deficit reached $1.97 trillion, with net interest payments alone totaling $1.02 trillion, the second-largest government expenditure after Social Security.
  • Persistent Inflation Risks: Geopolitical tensions, such as the U.S.-Iran conflict mentioned in the report, could create sustained mismatches in global oil supply and demand, posing a long-term risk of resurgent inflation.

Contagion Risk for Equities

Analysts at the firm believe the Fed is caught in a difficult position where any policy choice could lead to higher bond yields. If the Fed's tightening is insufficient, inflation could become entrenched; if it hikes too aggressively, the policy rate itself will push yields higher.

This environment poses a significant threat to U.S. stocks, particularly the technology sector. Zheshang Securities warns of a potential negative "Davis double-whammy," where rising risk-free rates compress stock valuations while higher borrowing costs simultaneously erode corporate earnings. This dynamic could increase the risk of a sharp correction in equities, potentially leading to a simultaneous sell-off in both the stock and bond markets.

Read next

More on Stocks
Shenzhen-Listed Jingxin Pharmaceutical Refiles for Hong Kong IPO

Stocks

Shenzhen-Listed Jingxin Pharmaceutical Refiles for Hong Kong IPO

Sep 20, 2026

Zhejiang Jingxin Pharmaceutical Co., Ltd. (002020.SZ) has resubmitted its application for a main board listing on the Hong Kong Stock Exchange, aiming to secure a dual listing to access international capital. The company specializes in drugs for central nervous system and cardiovascular diseases.

Back to latest news

LATEST